Written by Meredith Beirne

***excerpt***

“By rejecting Massachusetts’ 1115 waiver request to establish a closed Medicaid formulary and still receive 23.1% mandatory manufacturer rebates, the administration is protecting patients’ access to critical treatments and upholding the bargain that Congress struck with states and manufacturers in the 1990s,” said Lindsay Bealor Greenleaf, health policy expert and director at ADVI Health. “It’s a relief to see the administration do the right thing and reject this waiver request, because if Massachusetts had gotten its way, Medicaid patients would have limited treatment choices and industry would doubt whether future deals struck with the government will hold up over time.”

***end excerpt***

***

[/el-text]

View full article here